BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Thrasos Therapeutics 

86 South Street

Hopkinton  Massachusetts  01748  U.S.A.
Phone: 508-417-7202 Fax: 508-417-7212


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Discovery





 Company News
Thrasos Therapeutics Appoints Gaétan Gravel And Joseph Zakrzewski To Board Of Directors 8/12/2014 8:20:26 AM
Thrasos Therapeutics Appoints Donald Notman As Senior Vice President And Chief Financial Officer 6/18/2014 11:32:53 AM
Thrasos Therapeutics Presents Preclinical Data Demonstrating THR-184 Prevents Loss Of Kidney Function Following Acute Ischemic Injury 6/3/2014 9:54:32 AM
GlaxoSmithKline (GSK) Backs Thrasos Therapeutics With $35 Million for Acute Kidney Injury Tx Research 10/25/2012 7:12:09 AM
Thrasos Therapeutics and Collaborators Publish Nature Medicine Research Article Detailing Potential Treatment Approach for Kidney Disease 2/7/2012 6:54:02 AM
Thrasos Therapeutics Appoints Dr. Andreas Orfanos as Chief Medical Officer 9/20/2011 10:10:52 AM
Thrasos Therapeutics Initiates Phase 1 Clinical Trial for THR-184 in Acute Kidney Injury 9/13/2011 10:25:43 AM
Thrasos Therapeutics Issued U.S. Patent for First-in-Class Compounds That Selectively Target Key Receptors of the Bone Morphogenetic Protein Pathway 3/3/2009 9:24:05 AM
Biotech Veteran Wilcox To Become CEO Of Drug Discovery Company, Thrasos Inc. 4/17/2006 10:49:09 AM